Cargando…

Association of decreased triadin expression level with apoptosis of dopaminergic cells in Parkinson’s disease mouse model

BACKGROUND: Parkinson’s disease (PD) represent a loss of dopaminergic neurons in the substantia nigra (SN) of the midbrain. However, its cause remains unknown and Triadin (TRDN) function in the brain is also unknown. To examine the relationship between TRDN and PD, the expression levels of protein r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Seo, Min Hyung, Lim, Sabina, Yeo, Sujung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8567705/ https://www.ncbi.nlm.nih.gov/pubmed/34736417 http://dx.doi.org/10.1186/s12868-021-00668-7

Ejemplares similares

Triadin Decrease Impairs the Expression of E-C Coupling Related Proteins in Muscles of MPTP-Induced Parkinson’s Disease Mice
por: Seo, Min Hyung, et al.
Publicado: (2021)

Decrease in ITGA7 Levels Is Associated with an Increase in α-Synuclein Levels in an MPTP-Induced Parkinson’s Disease Mouse Model and SH-SY5Y Cells
por: Han, Sangeun, et al.
Publicado: (2021)

Association between Decreased ITGA7 Levels and Increased Muscle α-Synuclein in an MPTP-Induced Mouse Model of Parkinson’s Disease
por: Han, Sangeun, et al.
Publicado: (2022)

Association between Decreased SGK1 and Increased Intestinal α-Synuclein in an MPTP Mouse Model of Parkinson’s Disease
por: Seo, Min Hyung, et al.
Publicado: (2023)

Srpk3 Decrease Associated with Alpha-Synuclein Increase in Muscles of MPTP-Induced Parkinson’s Disease Mice
por: Seo, Min Hyung, et al.
Publicado: (2021)

Triadin/Junctin Double Null Mouse Reveals a Differential Role for Triadin and Junctin in Anchoring CASQ to the jSR and Regulating Ca(2+) Homeostasis
por: Boncompagni, Simona, et al.
Publicado: (2012)

Generation of a Triadin KnockOut Syndrome Zebrafish Model
por: Vecchi, Vanilla Martina, et al.
Publicado: (2021)

Quantification of the calcium signaling deficit in muscles devoid of triadin
por: Manno, Carlo, et al.
Publicado: (2022)

The Effects of Serping1 siRNA in α-Synuclein Regulation in MPTP-Induced Parkinson’s Disease
por: Seo, Min Hyung, et al.
Publicado: (2023)

Neuroprotective changes in degeneration-related gene expression in the substantia nigra following acupuncture in an MPTP mouse model of Parkinsonism: Microarray analysis
por: Yeo, Sujung, et al.
Publicado: (2015)

A Skeletal Muscle Ryanodine Receptor Interaction Domain in Triadin
por: Wium, Elize, et al.
Publicado: (2012)

A unique triadin exon deletion causing a null phenotype
por: O’Callaghan, Barry M., et al.
Publicado: (2018)

A study of the effects of 8-week acupuncture treatment on patients with Parkinson's disease
por: Yeo, Sujung, et al.
Publicado: (2018)

Caveolin 3 Is Associated with the Calcium Release Complex and Is Modified via in Vivo Triadin Modification†
por: Vassilopoulos, Stéphane, et al.
Publicado: (2010)

Dynamics of triadin, a muscle-specific triad protein, within sarcoplasmic reticulum subdomains
por: Sébastien, Muriel, et al.
Publicado: (2020)

Immunolocalization of sarcolemmal dihydropyridine receptor and sarcoplasmic reticular triadin and ryanodine receptor in rabbit ventricle and atrium
Publicado: (1995)

PEP-1-GLRX1 Reduces Dopaminergic Neuronal Cell Loss by Modulating MAPK and Apoptosis Signaling in Parkinson’s Disease
por: Choi, Yeon Joo, et al.
Publicado: (2021)

Absence of triadin, a protein of the calcium release complex, is responsible for cardiac arrhythmia with sudden death in human
por: Roux-Buisson, Nathalie, et al.
Publicado: (2012)

Cellular and electrophysiological characterization of triadin knockout syndrome using induced pluripotent stem cell-derived cardiomyocytes
por: Clemens, Daniel J., et al.
Publicado: (2023)

PEP-1-HO-1 prevents MPTP-induced degeneration of dopaminergic neurons in a Parkinson’s disease mouse model
por: Youn, Jong Kyu, et al.
Publicado: (2014)

CLR01 protects dopaminergic neurons in vitro and in mouse models of Parkinson’s disease
por: Bengoa-Vergniory, Nora, et al.
Publicado: (2020)

Triad formation: organization and function of the sarcoplasmic reticulum calcium release channel and triadin in normal and dysgenic muscle in vitro
Publicado: (1993)

Triadin Binding to the C-Terminal Luminal Loop of the Ryanodine Receptor is Important for Skeletal Muscle Excitation–Contraction Coupling
por: Goonasekera, Sanjeewa A., et al.
Publicado: (2007)

Dopaminergic Dysregulation, Artistic Expressiveness, and Parkinson's Disease
por: López-Pousa, S., et al.
Publicado: (2012)

Progranulin Gene Delivery Protects Dopaminergic Neurons in a Mouse Model of Parkinson’s Disease
por: Van Kampen, Jackalina M., et al.
Publicado: (2014)

Dopaminergic Neurodegeneration in the Mouse Is Associated with Decrease of Viscoelasticity of Substantia Nigra Tissue
por: Hain, Elisabeth G., et al.
Publicado: (2016)

Selenoprotein T Exerts an Essential Oxidoreductase Activity That Protects Dopaminergic Neurons in Mouse Models of Parkinson's Disease
por: Boukhzar, Loubna, et al.
Publicado: (2016)

Ketamine Does Not Exert Protective Properties on Dopaminergic Neurons in the Lactacystin Mouse Model of Parkinson’s Disease
por: Deneyer, Lauren, et al.
Publicado: (2018)

BMP5/7 protect dopaminergic neurons in an α-synuclein mouse model of Parkinson’s disease
por: Vitic, Zagorka, et al.
Publicado: (2020)

microRNA‐221 rescues the loss of dopaminergic neurons in a mouse model of Parkinson's disease
por: Yao, Yufang, et al.
Publicado: (2023)

Knockout or inhibition of USP30 protects dopaminergic neurons in a Parkinson’s disease mouse model
por: Fang, Tracy-Shi Zhang, et al.
Publicado: (2023)

IGF2 prevents dopaminergic neuronal loss and decreases intracellular alpha-synuclein accumulation in Parkinson’s disease models
por: Arcos, Javiera, et al.
Publicado: (2023)

Decreased NAD+ in dopaminergic neurons
por: Sison, Samantha L., et al.
Publicado: (2018)

Galectin-9/Tim-3 pathway mediates dopaminergic neurodegeneration in MPTP-induced mouse model of Parkinson’s disease
por: Peng, Qinyu, et al.
Publicado: (2022)

Parkinson's disease and dopaminergic neurons
Publicado: (2012)

Acupuncture on GB34 activates the precentral gyrus and prefrontal cortex in Parkinson’s disease
por: Yeo, Sujung, et al.
Publicado: (2014)

Parkinson’s disease: animal models and dopaminergic cell vulnerability
por: Blesa, Javier, et al.
Publicado: (2014)

Sodium Phenylbutyrate Controls Neuroinflammatory and Antioxidant Activities and Protects Dopaminergic Neurons in Mouse Models of Parkinson’s Disease
por: Roy, Avik, et al.
Publicado: (2012)

Impact of intravenous immunoglobulin on the dopaminergic system and immune response in the acute MPTP mouse model of Parkinson’s disease
por: St-Amour, Isabelle, et al.
Publicado: (2012)

Abnormal Development of Glutamatergic Synapses Afferent to Dopaminergic Neurons of the Pink1(−/−) Mouse Model of Parkinson’s Disease
por: Pearlstein, Edouard, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_464ore593lpg8g2o795s45me2f